MedTrace Logo

Autologous Adipose Tissue Derived Mesenchymal Stem Cells for Rotator Cuff Disease

NCT02474342 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 18

Last updated 2017-03-07

No results posted yet for this study

Summary

The purpose of this study is to evaluate safety and efficacy of Autologous Adipose Tissue Derived Mesenchymal Stem Cells injection in patient with Rotator Cuff disease.

Conditions

  • Rotator Cuff Disease

Interventions

BIOLOGICAL

Autologous Adipose Tissue Derived MSCs Transplantation

1. Study drugs: Autologous adipose tissue derived MSCs 2. Injection dosage and volume of the study drugs: * Low dose: 1x10e7 cells/3mL 3. Number of injections : only once during the study period 4. Device: Ultrasound 5. Injection technique: Injection into the lesion by investigator

BIOLOGICAL

Autologous Adipose Tissue Derived MSCs Transplantation

1. Study drugs: Autologous adipose tissue derived MSCs 2. Injection dosage and volume of the study drugs: * Mid dose: 5x10e7 cells/3mL 3. Number of injections : only once during the study period 4. Device: Ultrasound 5. Injection technique: Injection into the lesion by investigator

BIOLOGICAL

Autologous Adipose Tissue Derived MSCs Transplantation

1. Study drugs: Autologous adipose tissue derived MSCs 2. Injection dosage and volume of the study drugs: * High dose: 1x10e8 cells/3mL 3. Number of injections : only once during the study period 4. Device: Ultrasound 5. Injection technique: Injection into the lesion by investigator

Sponsors & Collaborators

  • Seoul National University Hospital

    lead OTHER

Principal Investigators

  • Chris H. Jo, M.D., Ph.D · Joint & Spine Center, SMG-SNU Boramae Medical Center, Department of Orthopedic Surgery, Seoul National University College of Medicine

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-07-07
Primary Completion
2016-11-30
Completion
2016-11-07

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02474342 on ClinicalTrials.gov